Instrumentation Funding Is Inadequate

Illustration: A. Canamucio Leading practitioners in most professions strive to work with the most up-to-date tools available, especially when faced with challenging tasks. Similarly, people relying on the skills of these top practitioners expect them to use the most advanced tools possible. Few patients, for example, would feel comfortable submitting to difficult medical procedures knowing their dentist, doctor, or surgeon was working with outdated instruments when a more modern version with su

Written byDavid Speicher
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Illustration: A. Canamucio

Leading practitioners in most professions strive to work with the most up-to-date tools available, especially when faced with challenging tasks. Similarly, people relying on the skills of these top practitioners expect them to use the most advanced tools possible. Few patients, for example, would feel comfortable submitting to difficult medical procedures knowing their dentist, doctor, or surgeon was working with outdated instruments when a more modern version with substantially superior capacities could be had.

Today, however, even with the promise of the complete human genome at hand, it is more difficult than ever for academic scientists to acquire the modern instrumentation they need to push their research programs forward. Other vital resources, including laboratory space, supplies, and salaries, are easier to obtain. Funding for instrumentation historically has been a low priority for both academic institutions and the government agencies that support most nonprofit research at these institutions. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies